Press release
Androgen Deprivation Therapy Industry Growth Outlook: 6% CAGR and $10.49 Billion by 2029
Get 30% off global market reports with code ONLINE30 and keep ahead of tariffs, macro trends, and worldwide economic developments.What Is the Long-Term Growth Forecast for the Androgen Deprivation Therapy Market Size 2025?
Over the past several years, the androgen deprivation therapy market has experienced a significant increase in its size. It is projected to expand from $7.81 billion in 2024 to $8.31 billion in 2025, reflecting a compound annual growth rate (CAGR) of 6.3%. The growth witnessed in the historical period was influenced by factors such as the increased global occurrence of prostate cancer, a rise in the elderly male population, high prostate cancer relapse rates, better survival rates promoting long-term treatment, and heightened consciousness regarding early screening for prostate cancer.
What CAGR is Forecasted for the Androgen Deprivation Therapy Market Through 2029?
The market for androgen deprivation therapy is predicted to flourish significantly in the upcoming years, rising to $10.49 billion in 2029 with a compound annual growth rate (CAGR) of 6.0%. This anticipated growth in the forecast period is due to the increased utilisation of combined therapies in oncology, growing incidence of hormone-sensitive cancers, a surge in diagnosed cases of both localized and advanced prostate cancer, wider application of ADT in non-oncology hormone conditions, and a rising trend of patients opting for non-invasive treatments. Key trends expected in the forecast period are improvements in depot formulations and delivery methods, the emergence of oral ADT medication, the advent of long-acting ADT injectables, the introduction of innovative androgen receptor inhibitors, and tech-driven advancements in digital pathology and diagnostics.
Explore The Complete Report Now:
https://www.thebusinessresearchcompany.com/report/androgen-deprivation-therapy-global-market-report
What Are the Critical Factors Driving Androgen Deprivation Therapy Market Development?
The anticipated rise in prostate cancer instances is predicted to boost the expansion of the androgen deprivation therapy market in the foreseeable future. Originating in the prostate gland, which is a part of the male reproductive system that produces seminal fluid, the occurrence of prostate cancer is primarily increasing due to extended life expectancies, as advancing age significantly increases susceptibility to the disease. Androgen deprivation therapy (ADT), the principal treatment approach for prostate cancer, is designed to reduce androgen levels that stimulate tumor growth. It is commonly employed in advanced or metastatic stages to slow down disease progression. For instance, Prostate Cancer UK, a prominent research, awareness, and support organization based in the UK, reported in January 2025 that the number of prostate cancer diagnoses in England had surged from 50,751 cases in 2022 to 55,033 cases in 2023, marking a notable annual increase. Thus, the escalating incidence of prostate cancer is propelling the growth of the androgen deprivation therapy market.
Get Free Sample Report Here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=25692&type=smp
How Does the Androgen Deprivation Therapy Market Break Down Across Major Segments?
The androgen deprivation therapy market covered in this report is segmented -
1) By Type: Medicine, Surgery, Other Types
2) By Route Of Administration: Injectable, Oral
3) By Patient Demographics: Men Aged 40-60, Men Aged 61-75, Men Above 75
4) By Application: Prostate Cancer, Other Applications
5) By End-User: Hospitals, Specialty Clinics, Other End-Users
Subsegments:
1) By Medicine: LHRH Agonists, LHRH Antagonists, Anti-Androgens, CYP17 Inhibitors, Steroidal Anti-Androgens, Non-Steroidal Anti-Androgens, Estrogen-Based Therapies, Combination Therapies
2) By Surgery: Bilateral Orchiectomy, Subcapsular Orchiectomy, Simple Orchiectomy
3) By Other Types: Radiopharmaceutical Therapy, Gene Therapy, Immunotherapy, Targeted Therapy, Cryotherapy, High-Intensity Focused Ultrasound (HIFU
What Are the Major Trends Transforming the Androgen Deprivation Therapy Industry?
Key players in the androgen deprivation therapy market are prioritizing the creation of advanced therapies, such as combined treatments, to enhance the effectiveness of advanced prostate cancer treatments. A combination therapy employs multiple modes of treatment, like hormone therapy in conjunction with chemotherapy, aiming to increase efficiency while slowing disease advancement. For example, Bayer AG, a life sciences organization based in Germany, gained the U.S. Food and Drug Administration's approval in August 2022 for the additional use of darolutamide together with docetaxel to treat metastatic hormone-responsive prostate cancer (mHSPC). The recently approved combination therapy focuses on improving survival rates and slowing disease progression in people diagnosed with metastatic hormone-responsive prostate cancer (mHSPC), which is a scenario where the cancer has metastasised but continues to be responsive to hormone treatments. The therapy stands out due to the inclusion of darolutamide, an orally administered medication that directly targets androgen receptors. Its distinct molecular structure allows for a strong bond with these receptors. Consequently, this effectively halts their functionality, leading to an inhibition in the growth and proliferation of prostate cancer cells.
Customize Your Insights And Get The Full Report Here:
https://www.thebusinessresearchcompany.com/customise?id=25692&type=smp
Which Players Are Driving Innovation in the Androgen Deprivation Therapy Market?
Major companies operating in the androgen deprivation therapy market are Pfizer Inc., Johnson & Johnson Services Inc., Merck & Co. Inc., Bayer AG, Bristol-Myers Squibb Company, AstraZeneca PLC, Novartis AG, Astellas Pharma Inc., Ipsen S.A., Dr. Reddy's Laboratories Ltd., Orion Corporation, Arvinas Inc., Ferring Pharmaceuticals SA, Tolmar Pharmaceuticals Inc., Besins Healthcare S.A., Veru Inc., Kintor Pharmaceutical Limited, Foresee Pharmaceuticals Co. Ltd., Verity Pharmaceuticals Inc., Lawley Pharmaceuticals Pty Ltd.
Which Regions Are Driving Global Androgen Deprivation Therapy Market Expansion?
North America was the largest region in the androgen deprivation therapy market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the androgen deprivation therapy market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
#Reach Out to Us#
Speak With Our Expert:
Saumya Sahay
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email: saumyas@tbrc.info
The Business Research Company - www.thebusinessresearchcompany.com
Follow Us On:
• LinkedIn: https://in.linkedin.com/company/the-business-research-company
Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.
Contact Us
Europe - +44 7882 955267,
Asia: +91 88972 63534,
Americas - +1 310-496-7795 or
Email: info@tbrc.info
Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Androgen Deprivation Therapy Industry Growth Outlook: 6% CAGR and $10.49 Billion by 2029 here
News-ID: 4157518 • Views: …
More Releases from The Business Research Company

Key Trends Reshaping the Nucleic Acid Extraction Instruments And Reagents Market …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
Nucleic Acid Extraction Instruments And Reagents Market Size Growth Forecast: What to Expect by 2025?
The market for nucleic acid extraction instruments and reagents has experienced a robust growth in the recent past. The market value is projected to rise from $4.56 billion in 2024 to $4.97 billion in…

Mobile ECG Devices Market Set To Soar Due To Escalating Incidence Of Heart-Relat …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
What Will the Mobile ECG Devices Industry Market Size Be by 2025?
In the past few years, the market size for mobile ECG devices has seen significant expansion. The growth rate is expected to rise from $115.35 billion in 2024 to $121.39 billion in 2025, indicating a compound annual…

Steady Expansion Forecast for Liver Cancer Diagnostics Market, Projected to Reac …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
Liver Cancer Diagnostics Market Size Valuation Forecast: What Will the Market Be Worth by 2025?
The market size for liver cancer diagnostics has seen significant expansion in the past few years. The market, which was valued at $9.69 billion in 2024, is expected to rise to $10.32 billion in…

Emerging Laser Atherectomy Devices Market Trends: Product Innovations In The Las …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
Laser Atherectomy Devices Market Size Growth Forecast: What to Expect by 2025?
In recent times, there has been significant growth in the market size for laser atherectomy devices. The market is projected to expand from $1.22 billion in 2024 to $1.3 billion in 2025, reflecting a compound annual growth…
More Releases for Androgen
U.S. Androgen Deprivation Therapy Adt Market Future Business Opportunities 2025- …
Coherent Market Insights has released a report titled "U.S. Androgen Deprivation Therapy Adt Market 2025-2032: Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2025-2032", which includes market percentage records and a thorough enterprise analysis. This report looks at the market's competition, geographic distribution, and growth potential. This comprehensive report encompasses industry performance, critical success factors, risk assessment, manufacturing prerequisites, project expenses, economic analysis, anticipated return on investment (ROI), and profit…
Androgen Deprivation Therapy Industry Growth Outlook: 6% CAGR and $10.49 Billion …
Get 30% off global market reports with code ONLINE30 and keep ahead of tariffs, macro trends, and worldwide economic developments.
What Is the Long-Term Growth Forecast for the Androgen Deprivation Therapy Market Size 2025?
Over the past several years, the androgen deprivation therapy market has experienced a significant increase in its size. It is projected to expand from $7.81 billion in 2024 to $8.31 billion in 2025, reflecting a compound annual growth…
Androgen Deprivation Therapy Industry Growth Outlook: 6% CAGR and $10.49 Billion …
Get 30% off global market reports with code ONLINE30 and keep ahead of tariffs, macro trends, and worldwide economic developments._x000D_
_x000D_
What Is the Long-Term Growth Forecast for the Androgen Deprivation Therapy Market Size 2025?_x000D_
Over the past several years, the androgen deprivation therapy market has experienced a significant increase in its size. It is projected to expand from $7.81 billion in 2024 to $8.31 billion in 2025, reflecting a compound annual growth…
Accelerating Growth: Androgen Deprivation Therapy Market and the Advantage in th …
The 𝐆𝐥𝐨𝐛𝐚𝐥 𝐀𝐧𝐝𝐫𝐨𝐠𝐞𝐧 𝐃𝐞𝐩𝐫𝐢𝐯𝐚𝐭𝐢𝐨𝐧 𝐓𝐡𝐞𝐫𝐚𝐩𝐲 𝐌𝐚𝐫𝐤𝐞𝐭 𝐑𝐞𝐩𝐨𝐫𝐭 dissects the complex fragments of the Market in an easy-to-read manner. This report covers drivers, restraints, challenges, and threats in the Androgen Deprivation Therapy Market to understand the overall scope of the Market in a detailed yet concise manner.
Additionally, the Market report covers the top-winning strategies implemented by major industry players and technological advancements that steer the growth of the Market.
…
Androgen Deprivation Therapy (ADT) Market Analysis and Future Prospects for 2030
The world of the androgen deprivation therapy (adt) market is a complex and ever-evolving landscape, shaped by consumer demands and technological advancements. In this report, we delve into the depths of this market to provide a profound and comprehensive analysis, catering to a diverse audience that includes manufacturers, suppliers, distributors, and investors. Our primary goal is to empower industry stakeholders with invaluable insights to make informed decisions in a rapidly…
Androgen Replacement Therapy Market Status and Trend Analysis 2017-2032 (COVID-1 …
From 2023 to 2032, the market for androgen replacement therapy is expected to increase at a CAGR of 3.5%, holding USD 1736.9 million in 2020. The term hormone replacement therapy is frequently used to refer to androgen replacement therapy. The effects of decreased gonad development are countered. Male hypogonadism is a clinical disease that prevents the production of physiological testosterone levels in testing. A test issue may be the main…